JAG1 — Jagged 1

JAG1 — Jagged 1

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">JAG1 — Jagged 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>JAG1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Jagged 1 (Notch Ligand)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>20p12.2</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/1950" target="_blank">1950</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000101384" target="_blank">ENSG00000101384</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/184756" target="_blank">184756</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P78504" target="_blank">P78504</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1,218 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~134 kDa</td></tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), Alagille Syndrome, Deafness</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Cerebral [cortex](/brain-regions/cortex), Cochlea, Liver, Heart</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color

JAG1 — Jagged 1

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">JAG1 — Jagged 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>JAG1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Jagged 1 (Notch Ligand)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>20p12.2</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/1950" target="_blank">1950</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000101384" target="_blank">ENSG00000101384</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/184756" target="_blank">184756</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P78504" target="_blank">P78504</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1,218 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~134 kDa</td></tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), Alagille Syndrome, Deafness</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Cerebral [cortex](/brain-regions/cortex), Cochlea, Liver, Heart</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/cardiac" style="color:#ef9a9a">Cardiac</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">95 edges</a></td>
</tr>
</table>

JAG1 — Jagged 1

Overview

JAG1 (Jagged 1), also known as CD339, is a critical member of the Notch ligand family that plays essential roles in cell fate determination, embryonic development, tissue homeostasis, and increasingly recognized functions in neurodegeneration. Located on chromosome 20p12.2, this gene encodes a 1,218-amino acid transmembrane protein that serves as a ligand for Notch receptors (NOTCH1-4), triggering canonical Notch signaling cascades that influence gene expression programs throughout development and adult life[^berezov2012].

The JAG1-Notch axis has garnered significant attention in neurodegeneration research due to its involvement in Alzheimer's disease pathogenesis, neurogenesis regulation, neuroinflammation, and synaptic plasticity. Elevated JAG1 expression has been documented in Alzheimer's disease brains, and the protein interfaces with amyloid-beta pathology, tau pathology, and neuronal survival pathways. Beyond AD, JAG1 has relevance to other neurodegenerative conditions and developmental disorders, making it a significant node at the intersection of developmental biology and age-related neurodegeneration[@lau2020][^lau2020].

Gene and Protein Structure

Gene Organization

| Feature | Details |
|---------|---------|
| Gene Symbol | JAG1 (CD339, JAG1, Serrate-1) |
| Full Name | Jagged 1 |
| Chromosomal Location | 20p12.2 |
| NCBI Gene ID | 1950 |
| OMIM | 184756 |
| Ensembl ID | ENSG00000101384 |
| UniProt | P78504 |
| Protein Length | 1,218 amino acids |
| Molecular Weight | ~134 kDa |

Protein Domain Architecture

JAG1 is a type I transmembrane protein with complex domain organization:

The extracellular domain undergoes proteolytic cleavage (S1 cleavage) to produce a soluble form, and the remaining membrane-bound fragment can undergo S2 cleavage by ADAM proteases to release the intracellular domain (NICD) for nuclear signaling.

Alternative Splicing

Multiple JAG1 isoforms have been described:

• Full-length transmembrane isoform (canonical)
• Soluble isoforms generated by alternative splicing or proteolysis
• Cell-type specific isoforms with distinct signaling properties

Biological Functions

Notch Receptor Activation

JAG1 activates Notch receptors through cell-cell contact:

Notch Receptor Family:

• NOTCH1: Ubiquitous expression, diverse functions
• NOTCH2: Brain, immune system
• NOTCH3: Vascular smooth muscle, CNS
• NOTCH4: Endothelial cells

Key Signaling Pathways

Canonical Notch Signaling:

Non-canonical Pathways:

• Notch interactions with other receptors
• JAG1-independent Notch activation
• Cross-talk with Wnt, Hedgehog, BMP pathways

Role in Neurodegeneration

Alzheimer's Disease

JAG1 has emerged as a significant player in AD pathogenesis[@chen2023][^berezov2012][^chen2023]:

1. Amyloid-Beta Interaction

• JAG1 expression elevated in AD brain
• Aβ enhances JAG1 expression in neurons and glia
• JAG1-Notch signaling intersects with APP processing
• NICD generation modified by Aβ exposure

• Notch signaling affects tau phosphorylation
• JAG1 modulates tau-related gene expression
• Potential cross-talk in neurofibrillary tangle formation

• JAG1 in microglial activation
• Notch-mediated cytokine production
• Neuroinflammatory amplification loop[^song2022]

• Notch regulates synaptic plasticity genes
• JAG1-Notch affects LTP and memory formation
• Contributes to early synaptic deficits

• Adult hippocampal neurogenesis impaired in AD
• JAG1-Notch affects neural stem cell fate
• Links to cognitive decline

Parkinson's Disease

Though less studied, JAG1 has relevance to PD:

1. Dopaminergic Development

• Notch signaling in dopaminergic neuron specification
• JAG1 expression in substantia nigra
• May affect neuronal survival

• Notch activation influences α-synuclein aggregation
• Potential cross-talk in synucleinopathy
• Neuronal vulnerability modulation

• Microglial Notch signaling in PD
• JAG1 in inflammatory responses

Amyotrophic Lateral Sclerosis

In ALS, JAG1 contributes through:

1. Motor Neuron Development

• Notch in motor neuron specification
• Altered JAG1 expression in ALS
• Developmental vulnerability

• Astrocytic JAG1 affecting motor neurons
• Non-cell autonomous toxicity
• Notch-mediated signaling inglia

Other Neurodegenerative Conditions

• Huntington's Disease: Notch in striatal neuron function
• Multiple Sclerosis: JAG1 in demyelination
• Stroke: Notch in ischemia response

Expression Patterns

Brain Regional Distribution

| Brain Region | Expression Level | Notes |
|-------------|-----------------|-------|
| Hippocampus | High | CA1-CA3, dentate gyrus |
| Cerebral Cortex | High | Layer 5 pyramidal neurons |
| Subventricular Zone | High | Neural stem cells |
| Substantia Nigra | Moderate | Dopaminergic neurons |
| Cerebellum | Moderate | Purkinje cells |

Cell-Type Specificity

• Neurons: High expression, particularly pyramidal neurons
• Astrocytes: Moderate, increases with activation
• Microglia: Inducible expression under stress
• Oligodendrocytes: Lower expression
• Neural Stem Cells: High for fate decisions

Non-CNS Expression

JAG1 is widely expressed outside the CNS:

• Cochlea: Inner ear development, deafness in Alagille
• Vascular system: Angiogenesis
• Liver: Bile duct development
• Heart: Valve formation

Interaction Network

Notch Receptors

| Receptor | Interaction | Primary Functions |
|----------|-------------|-------------------|
| NOTCH1 | Primary | Diverse, ubiquitous |
| NOTCH2 | Strong | Brain, immune |
| NOTCH3 | Moderate | Vascular, CNS |
| NOTCH4 | Weaker | Endothelial |

Co-factors and Modulators

• DLL ligands: JAG1 co-operates with DLL1, DLL4
• Fringe proteins: Modify JAG1-Notch specificity
• ADAM proteases: S2 cleavage (TACE/ADAM17)
• γ-secretase: S3 cleavage (presenilins)

Downstream Targets

HES/HEY Family:

• HES1, HES5: Master regulators
• HEY1, HEY2: Cardiovascular, neuronal

• Cyclin D1 (cell cycle)
• c-Myc (proliferation)
• NF-κB components
• Notch1 itself (feedback)

Therapeutic Implications

Therapeutic Target Rationale

Modulating JAG1-Notch offers therapeutic potential[^chen2023]:

1. γ-Secretase Inhibitors

• Prevent NICD generation
• Clinical trials in AD (failed, too broad)
• Next-gen selective inhibitors

• Monoclonal antibodies against Notch
• Engineered decoy receptors
• Small molecule modulators

• JAG1 neutralizing antibodies
• Peptide blockers of JAG1-Notch interaction
• Soluble JAG1 for pathway modulation

Challenges

• Developmental toxicity: Notch inhibition affects many processes
• Bidirectional effects: Both protective and pathogenic roles
• Selectivity: JAG1 vs. other ligands
• CNS delivery: Blood-brain barrier challenges

Preclinical Approaches

• Antibody-based therapies
• Small molecule γ-secretase modulators
• Natural compounds affecting Notch
• Gene therapy targeting JAG1

Genetic Variants

Disease-Associated Variants

• Alagille Syndrome: ~40% caused by JAG1 mutations
• Tetralogy of Fallot: Associated variants
• Deafness: Cochlear expression variants

Alzheimer's Disease

• No strong AD-associated JAG1 variants
• Expression quantitative trait loci (eQTLs)
• Potential modifier effects

Research Directions

Key Questions

Emerging Research

• Single-cell Notch pathway analysis
• Structure-based inhibitor design
• Brain-penetrant Notch modulators
• Combination with anti-Aβ therapies

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/als)
• [Notch Signaling Pathway](/mechanisms/notch-signaling)
• [Amyloid Hypothesis](/mechanisms/amyloid-hypothesis)
• [Tau Pathology](/mechanisms/tau-pathology)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Adult Neurogenesis](/mechanisms/neurogenesis)

External Links

• [NCBI Gene: JAG1](https://www.ncbi.nlm.nih.gov/gene/1950)
• [UniProt: JAG1](https://www.uniprot.org/uniprot/P78504)
• [Ensembl: JAG1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000101384)
• [OMIM: JAG1](https://www.omim.org/entry/184756)

References

Mechanistic Pathway: JAG1-Notch in Alzheimer's Disease

Notch Pathway in Neurobiology

Neurogenesis and Neural Stem Cells

Notch signaling maintains neural stem cell pools:

• Lateral inhibition: Differentiating neurons inhibit neighbors
• Self-renewal: Notch promotes stem cell maintenance
• Astrocyte vs. neuron fate: Notch influences differentiation

Synaptic Plasticity

Notch contributes to learning and memory:

• LTP modulation: Notch affects synaptic strengthening
• Memory formation: Notch target genes in hippocampus
• Cognitive function: Notch dysregulation impairs cognition

Glial Development

• Oligodendrocyte differentiation regulated by Notch
• Astrocyte fate specification
• Microglial activation states

Cross-Talk with Other Pathways

Interactions with AD-Related Pathways

| Pathway | Interaction | Outcome |
|---------|-------------|---------|
| APP/Aβ | Bidirectional | JAG1 affects APP, Aβ affects Notch |
| Tau | Phosphorylation | Notch affects kinases/phosphatases |
| Neuroinflammation | NF-κB | Notch and NF-κB cross-talk |
| Wnt | Transcriptional | Convergence on common targets |
| BMP | Receptor-level | Competition/modulation |

Cell-Cell Communication

JAG1-mediated Notch signaling is unique:

• Requires direct cell-cell contact
• Forms communication channels
• Coordinates tissue-level decisions

Biomarker Development

Expression Biomarkers

• JAG1 mRNA in blood cells
• Soluble JAG1 in CSF
• Notch target genes as readouts

Clinical Applications

• Disease progression markers
• Therapeutic response monitoring
• Patient stratification

Age-Related Changes

Aging and Notch

• Declining Notch activity with age
• Reduced neurogenesis in aging
• Increased JAG1 in pathological aging
• Therapeutic window for modulation

Animal Models

Genetic Models

• Knockout mice: embryonic lethal
• Conditional deletion in CNS
• Transgenic overexpression
• Humanized models

Phenotypic Analysis

• Learning and memory tests
• Neurogenesis assessment
• Amyloid and tau pathology
• Electrophysiology

Research Directions and Unanswered Questions

Critical Knowledge Gaps

Emerging Areas

• Cryo-EM structures of JAG1-Notch complexes
• Single-cell pathway analysis
• Brain-penetrant modulators
• Gene therapy approaches

Pathway Diagram

The following diagram shows the key molecular relationships involving JAG1 — Jagged 1 discovered through SciDEX knowledge graph analysis: